Biopharmaceuticals
Developing advanced biologic therapies to treat rare diseases and cancer through cutting-edge drug discovery and personalized medicine
Therapeutic Focus Areas
Oncology
Developing immunotherapy and targeted therapies for difficult-to-treat cancers with high success rates
Key Features:
- •Immunotherapy treatments
- •Targeted therapy approaches
- •CAR-T cell therapy
- •Precision medicine
Applications:
- ✓Solid tumors
- ✓Hematologic malignancies
- ✓Rare cancers
- ✓Metastatic disease
Rare Diseases
Research and development of therapies for rare diseases, bringing hope to patients with no treatment options
Key Features:
- •Gene therapy solutions
- •Enzyme replacement therapy
- •Orphan drug development
- •Personalized treatments
Applications:
- ✓Genetic disorders
- ✓Metabolic diseases
- ✓Neurological conditions
- ✓Muscular dystrophies
Autoimmune Diseases
Developing biologic therapies to treat autoimmune diseases like rheumatoid arthritis and lupus
Key Features:
- •Monoclonal antibodies
- •Biologic DMARDs
- •Targeted therapy
- •Immune modulation
Applications:
- ✓Rheumatoid arthritis
- ✓Systemic lupus erythematosus
- ✓Multiple sclerosis
- ✓Inflammatory bowel disease
Drug Development Pipeline
Phase III
Drugs in Phase III clinical trials with potential for commercialization within 2-3 years
Phase II
Drugs in Phase II clinical trials with promising initial efficacy data
Phase I
New drugs in Phase I clinical trials with breakthrough potential in treatment
Research Achievements
Manufacturing Excellence
Biologics Plant Seoul
Seoul, South Korea
Biopharmaceutical manufacturing facility in Seoul with 50,000L capacity, producing monoclonal antibodies
Technologies:
Key Results:
- •FDA approved facility
- •ISO 14001 certified
- •Real-time monitoring systems
Cell Therapy Center Basel
Basel, Switzerland
Cell therapy manufacturing center in Basel with advanced CAR-T cell therapy technology
Technologies:
Key Results:
- •GMP certified operations
- •Automated cell processing
- •Quality assurance systems
Gene Therapy Facility Boston
Boston, USA
Gene therapy manufacturing facility in Boston with viral vector and gene editing technology
Technologies:
Key Results:
- •FDA breakthrough designation
- •Advanced vector production
- •Precision gene editing
Research & Development
Research Centers
AI Drug Discovery
Using artificial intelligence to accelerate drug discovery and predict treatment efficacy
CRISPR Gene Editing
Developing gene therapies using CRISPR technology to treat genetic diseases
Organoid Technology
Using organoid technology to model diseases and test drugs in 3D environments
Strategic Partnerships
Pfizer
Vaccine and biologic therapy development
Joint development of vaccines and biologic therapies
Merck
Cancer research and immunotherapy
Cancer research and immunotherapy development
Johnson & Johnson
Cell and gene therapy development
Cell therapy and gene therapy development
Novartis
Rare disease treatments
Rare disease treatment development
The Future of Biopharmaceuticals
Personalized Medicine
Tailored treatments based on individual genetic profiles and disease characteristics
Applications:
- •Genetic profiling
- •Biomarker identification
- •Custom drug formulations
- •Precision dosing
AI-Driven Drug Discovery
Next-generation AI systems that continuously learn and optimize drug development processes
Applications:
- •Machine learning algorithms
- •Predictive modeling
- •Virtual clinical trials
- •Automated compound screening
Gene Therapy Revolution
Advanced gene editing technologies for curing genetic diseases at the source
Applications:
- •CRISPR gene editing
- •Viral vector delivery
- •Gene replacement therapy
- •Epigenetic modifications
The Future of Biopharmaceuticals
Partner with WMTAN Group to develop advanced biologic therapies that save lives and improve quality of life for patients worldwide.
Biopharmaceuticals Team:portal.wmtan.com/biopharma|Email:biopharma@wmtan.com